Cholangitis diagnostic criteria: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
{{familytree | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | {{familytree | | |,|-|-|-|-|-|-|-|+|-|-|-|-|-|-|.| }} | ||
{{familytree | | |!| | | | | | | |!| | | | | | |!| }} | {{familytree | | |!| | | | | | | |!| | | | | | |!| }} | ||
{{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br><br>Signs of infection and pus finding in bile during:<br>•[[ERCP]]<br>•[[PTCA]]<br>•Surgery|B02='''Charcot triad'''<br>•[[Fever]]<br>•[[Jaundice]]<br>•[[Abdominal pain]]<br><br>'''Reynold's pentad''' (includes 2 extra features)<br>•[[Sepsis]]<br>•[[Mental confusion]]|B03= '''Tokyo guidelines 2013(TG 13)‡ '''<br><br>A.'''Systemic inflammation'''<br>A-1. [[Fever]] and/or shaking [[chills]]<br>A-2. Laboratory data: evidence of inflammatory response<br><br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br><br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br><br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}} | {{familytree |boxstyle=text-align: left| |B01| | | | | |B02| | | | |B03|B01='''Definitive diagnosis'''<br><br>Signs of infection and pus finding in bile during:<br>•[[ERCP]]<br>•[[PTCA]]<br>•Surgery|B02='''Charcot triad'''<br>•[[Fever]]<br>•[[Jaundice]]<br>•[[Abdominal pain]]<br><br>'''Reynold's pentad''' (includes 2 extra features)<br>•[[Sepsis]]<br>•[[Mental confusion]]|B03= '''Tokyo guidelines 2013(TG 13)<sup>‡</sup> '''<br><br>A.'''Systemic inflammation'''<br>A-1. [[Fever]] and/or shaking [[chills]]<br>A-2. Laboratory data: evidence of inflammatory response<br><br>B.'''Cholestasis'''<br>B-1. Jaundice<br>B-2. Laboratory data: abnormal liver function tests<br><br>C.'''Imaging'''<br>C-1. Biliary dilatation<br>C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.)<br><br>Suspected diagnosis: One item in A + one item in either B or C<br>'''Definite diagnosis''': One item in A, one item in B and one item in C}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 21:01, 14 December 2017
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Cholangitis diagnostic criteria |
|
Risk calculators and risk factors for Cholangitis diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Diagnostic criteria
An algorithm for diagnosis of cholangitis:[1][2]
| Diagnosis of acute cholangitis | |||||||||||||||||||||||||||||||||||||
| Definitive diagnosis Signs of infection and pus finding in bile during: •ERCP •PTCA •Surgery | Charcot triad •Fever •Jaundice •Abdominal pain Reynold's pentad (includes 2 extra features) •Sepsis •Mental confusion | Tokyo guidelines 2013(TG 13)‡ A.Systemic inflammation A-1. Fever and/or shaking chills A-2. Laboratory data: evidence of inflammatory response B.Cholestasis B-1. Jaundice B-2. Laboratory data: abnormal liver function tests C.Imaging C-1. Biliary dilatation C-2. Evidence of the etiology on imaging (stricture, stone, stent etc.) Suspected diagnosis: One item in A + one item in either B or C Definite diagnosis: One item in A, one item in B and one item in C | |||||||||||||||||||||||||||||||||||
Note: ERCP= Endoscopic retrograde cholangiopancreatography, PTCA =Percutaneous transhepatic cholangiography
A-2: Abnormal white blood cell counts, increase of serum C-reactive protein levels, and other changes indicating inflammation
B-2: Increased serum ALP, cGTP (GGT), AST and ALT levels.
| Thresholds TG-13‡ | |||
|---|---|---|---|
| Category‡ | Clinical/
Lab feature |
Test/Units | Value |
| A1 | Fever | Body temp | >38° C |
| A2 | Evidence of inflammatory response | WBC (x1000μ/lL) | <4 or>10 |
| CRP (mg/dl) | ≥1 | ||
| B1 | Jaundice | Total bilirubin
(mg/dL) |
≥ 2 |
| B2 | Abnormal liver function test | ALP (IU) | >1.5 x STD |
| γGTP (IU) | >1.5 x STD | ||
| AST (IU) | >1.5 x STD | ||
| AST (IU) | >1.5 x STD | ||
STD=upper limit of normal value, ALP= alkaline phosphatase, γGTP (GGT)= γ-glutamyltransferase, AST= aspartate aminotransferase, ALT= alanine aminotransferase
References
- ↑ Lee, John G. (2009). "Diagnosis and management of acute cholangitis". Nature Reviews Gastroenterology & Hepatology. 6 (9): 533–541. doi:10.1038/nrgastro.2009.126. ISSN 1759-5045.
- ↑ Kiriyama, Seiki; Takada, Tadahiro; Strasberg, Steven M.; Solomkin, Joseph S.; Mayumi, Toshihiko; Pitt, Henry A.; Gouma, Dirk J.; Garden, O. James; Büchler, Markus W.; Yokoe, Masamichi; Kimura, Yasutoshi; Tsuyuguchi, Toshio; Itoi, Takao; Yoshida, Masahiro; Miura, Fumihiko; Yamashita, Yuichi; Okamoto, Kohji; Gabata, Toshifumi; Hata, Jiro; Higuchi, Ryota; Windsor, John A.; Bornman, Philippus C.; Fan, Sheung-Tat; Singh, Harijt; de Santibanes, Eduardo; Gomi, Harumi; Kusachi, Shinya; Murata, Atsuhiko; Chen, Xiao-Ping; Jagannath, Palepu; Lee, Sung Gyu; Padbury, Robert; Chen, Miin-Fu; Dervenis, Christos; Chan, Angus C.W.; Supe, Avinash N.; Liau, Kui-Hin; Kim, Myung-Hwan; Kim, Sun-Whe (2013). "TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos)". Journal of Hepato-Biliary-Pancreatic Sciences. 20 (1): 24–34. doi:10.1007/s00534-012-0561-3. ISSN 1868-6974.